Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Beth Leventhal Fromkin, MD was born and raised in Brooklyn, NY. She has been with Cleveland Clinic Florida in the Department of Nephrology since 2001.
She is a graduate of Stuyvesant High School and Princeton University. She attended medical school at Albert Einstein College of Medicine of Yeshiva University in Bronx, NY. She completed her internal medicine Residency at Yale-New Haven Hospital in New Haven, CT and completed her fellowship in Nephrology at NY Presbyterian Hospital Cornell Medical Center in New York, NY. After completing her nephrology fellowship, she then completed a second fellowship in Hypertension at NY Presbyterian Hospital Cornell Medical Center in New York, NY. She is board certified in Nephrology by the American Board of Internal Medicine and is also board certified in Hypertension by the American Society of Hypertension. She is currently one of only 46 board certified hypertension specialists in the State of Florida.
Dr. Beth Fromkin specializes in all aspects of inpatient and outpatient kidney disease and has expertise in renal transplant medicine. She treats complex and secondary causes of hypertension. She performs hemodialysis, peritoneal dialysis, CVV-H, and CVV-HD. She performs kidney biopsies and treats vasculitis and nephritis. She is an active teacher in the Department's fully accredited Nephrology fellowship program. She is active in the Princeton University Alumni Association.
Chronic kidney disease, dialysis, dialysis chronic kidney disease, dialysis and kidney biopsy, end stage renal disease, general nephrology, glomerulonephritis, hypertension, predialysis care, renal biopsies, renal diseases, renal transplantation medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Fromkin's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.